Innovation Pharma and George Mason University released lab testing results for Brilacidin’s COVID-19 treatment
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
-
-
REGN-COV2 IDMC recommended holding enrollment in hospitalized patients with high oxygen requirements
On Oct. 30, 2020, Regeneron announced that it had received a recommendation from the independent data monitoring committee…
-
Icosavax launched COVID-19 vaccine program with preclinical data and $16.5 million in new funding
On Oct. 30, 2020, Icosavax announced the launch of the company’s COVID-19 vaccine program with preclinical data on…
-
Oxford University began COVID-19 test for individuals without symptoms
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
-
Mammoth Biosciences announced agreements targeting high-throughput CRISPR-based SARS CoV-2 test
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine
OncoSec announced FDA clearance of IND application for phase 1 clinical trial of CORVax12 vaccine candidate for COVID-19
On Oct. 29, 2020, OncoSec Medical announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
PerkinElmer COVID-19 test kit receives FDA Emergency Use Authorization for sample pooling
On Oct. 29, 2020, PerkinElmer announced that its New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Medical Device | Organoids | Vaccine
Emulate collaborated with FDA to apply lung-chip to evaluate safety of COVID-19 vaccines
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
-
CVS Health expanded COVID-19 testing services with 1,000 rapid-result test sites
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
-
NIH scientists discovered key pathway in lysosomes that coronaviruses use to exit cells
On Oct. 28, 2020, researchers at the National Institutes of Health (NIH) announced that they had discovered a…
-
Data for Lilly’s bamlanivimab (LY-CoV555) in COVID-19 outpatients published in NEJM
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
-
Lilly announced agreement with US government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab to fight COVID-19
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
-
Regeneron’s COVID-19 outpatient trial demonstrated that REGN-COV2 antibody significantly reduced virus levels
On Oct. 28, 2020, Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the…
-
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
Nektar Therapeutics announced phase 1b clinical study to evaluate empegaldesleukin for treatment of patients with COVID-19
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
-
Additional COVID-19 related genes – both helpful and harmful – revealed in massive screen
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
-
Antibodies co-invented by Scripps Research and IAVI developed as a potential COVID-19 therapy
On Oct. 26, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
-
PerkinElmer Obtains CE Mark For PKamp Respiratory SARS-CoV-2 RT-PCR Panel
On Oct. 26, 2020, PerkinElmer announced that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel had received clearance to be…
-
Taconic Biosciences launched critical model for COVID-19 research
On Oct. 26, 2020, Taconic Biosciences announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2…
-
Membrion molecular coating to prevent COVID-19 virus from passing through cloth face masks
On Oct. 26, 2020, Membrion announced it was pioneering a mask spray that binds COVID-19 molecules on the…
-
Entos Pharma awarded $5 million in NRC IRAP funding to conduct phase I Clinical trial of COVID-19 DNA vaccine
On Oct. 23, 2020, Entos Pharmaceuticals announced it was receiving advisory services and funding of up to $5…
-
FDA authorised restart of the COVID-19 AZD1222 vaccine US phase III trial
On Oct. 23, 2020, AstraZeneca announced that the clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, had…
-
Johnson & Johnson prepared to resume phase 3 ENSEMBLE trial of COVID-19 vaccine candidate in the US
On Oct. 23, 2020, Johnson & Johnson announced that it was preparing to resume recruitment in the pivotal…
-
Oxford Immunotec selected as sole supplier of UK T cell testing for SARS-CoV-2 COVID vaccine trials
On Oct. 22, 2020, Oxford Immunotec announced that it had been selected to provide T cell testing to…
-
WHO and Wikimedia Foundation expanded access to trusted information about COVID-19 on Wikipedia
On Oct. 22, 2020, the World Health Organization (WHO) and the Wikimedia Foundation announced a collaboration to expand…
-
IAVI, Merck, and Serum Institute joined forces to develop monoclonal antibodies for COVID-19
On Oct. 22, 2020, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges,…
-
Biotechnology | COVID-19 | FDA | Therapeutics
FDA approved Gilead’s antiviral Veklury (remdesivir) for treatment of COVID-19
On Oct. 22, 2020, Gilead Sciences announced that the FDA had approved the antiviral drug Veklury (remdesivir) for…
-
ImmunityBio, NantKwest announced first patient dosed in phase 1 clinical trial of second-generation COVID-19 vaccine candidate
On Oct. 21, 2020, ImmunityBio and NantKwest announced that the first patient had been dosed in the Phase…
-
CerTest Biotec and BD announced CE Mark for combination COVID-19, Influenza, RSV test
On Oct. 21, 2020, CerTest Biotec, along with BD (Becton, Dickinson), announced that the VIASURE SARS-CoV-2 (N1 +…
-
PerkinElmer immunoassay identiied therapeutic compounds capable of disrupting the SARS-CoV-2 spike protein/ACE2 interaction
On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences…
